Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1290386

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1290386

Global Plastic Surgery Market - 2023-2030

PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Market Overview

The Global Plastic Surgery Market reached US$ 69.7 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 158.7 billion by 2030. The global plastic surgery market is expected to exhibit a CAGR of 11.1% during the forecast period (2023-2030). The increasing technological advancements and the growing clinical trials for novel products are driving demand for plastic surgery.

The hottest topics in town right now are cosmetic or plastic procedures. The least invasive procedures that are generally deemed safe include those involving fillers, neurotoxins, lasers, and energy devices. According to the American Society for Aesthetic Plastic Surgery, women in their 30s are having cosmetic operations performed more frequently, and 30% of liposuction patients are between the ages of 19 and 34.

The plastic surgery market scope comprises surgical procedure types such as reconstructive surgical procedures, cosmetic (aesthetic) surgical procedures, and cosmetic minimally-invasive procedures, which has increased the plastic surgery market share. The global market for plastic surgery is expanding as a result of factors including increasing research and development and the upcoming novel product approvals by various key players across countries.

Market Dynamics

The Rising Novel Product Launches Drive the Growth of the Plastic Surgery Market

Instances of dysfunction or inconsistency, such as congenital impairments or injuries, are addressed by plastic surgery. In order to improve the attractiveness, cosmetic surgery is used. According to the American Academy of Cosmetic Surgery, plastic surgery is used to improve the look or treat bodily parts that are not working properly.

One might choose to have plastic surgery, for instance, to assist repair serious burns, or congenital impairments, or to rebuild the breast following a mastectomy. Instead of improving the look for medicinal reasons, cosmetic surgery focuses on aesthetic considerations. People may undergo cosmetic surgery, such as a facelift or nose surgery, to alter the appearance of their face or body.

On April 26, 2023, Galderma disclosed that Sculptra, an injectable version of poly-L-lactic acid (PLLA-SCA), was given FDA approval to address wrinkles as well as fine lines around the cheeks. Sculptra successfully addressed cheek wrinkles during smiling for up to two years, which was its secondary goal, and its main efficacy endpoint of a 1-grade reduction in cheek wrinkles at rest. Hence, the growing number of novel product launches is driving the plastic surgery market.

Rising Clinical Trials and Research and Development Create Lucrative Opportunities for Manufacturers

Contributions to clinical research and fundamental science research from a number of researchers or fellows have accelerated the development of novel treatments and significantly improved our understanding of the origins and course of the disease. Several clinical trials are being conducted resulting in positive outcomes.

At the World Congress International Master Course on Aging Science 2023 in Paris, Evolus, Inc., a performance beauty company with a customer-centric strategy committed to delivering ground-breaking products, presented interim data from its Phase II clinical study evaluating an "extra-strength" creation for a longer duration of Jeuveau (prabotulinumtoxinA-xvfs), its flagship neurotoxin product. According to the results, Jeuveau's "extra-strength" formulation at 40U (units) produced a duration profile of six months or twenty-six weeks. Thus, these factors will drive the growth of the plastic surgery market size.

High Risks and Complications Associated with These Surgeries will Hamper the Growth of the Market.

Hematoma is a sizable, uncomfortable bruise that resembles a bloody pocket. This outcome happens in 1 to 6% of breast augmentation surgeries; it can also happen as a side effect of a facelift. Unexpectedly, you might also require additional surgery to remove the blood from a hematoma. This problem occurs almost always during operations.

Furthermore, one of the most frequent postoperative consequences is infection. Cellulitis following breast surgery is a potential complication that may affect 2 to 4 percent of patients. Some infections could be more serious than others and call for intravenous antibiotics. Hence, the above mentioned factors are limiting the plastic surgery market's growth.

COVID-19 Impact Analysis

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, during the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a low impact on the global plastic surgery market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global plastic surgery market growth over the forecast period.

Segment Analysis

The global plastic surgery market is segmented based on surgical procedure type, gender, age group, end user and region.

Age Group (30-39) Segment Accounts for 38.1% of the Market Share Owing to the Rising Adoption of Plastic Surgery by This Age Group

Historically, everyone between the ages of 18 and 70 was considered a good candidate for plastic surgery. This is due to the fact that most cosmetic operations perform at their peak once the body has reached its full adult size. Males typically attain adult size between ages 15 and 18, whilst girls typically do so between ages 14 and 18.

Up to 1 million Botox treatments are performed annually on people in this age group, making them the most popular cosmetic procedure. Liposuction or breast augmentation comes next. The "Mommy Makeover" is often chosen by women who are finished having children. This entails a thorough range of procedures designed to get the body back to how it was before getting pregnant. They consist of liposuction, breast lift procedures, and stomach tucks.

The 30-45 age group has the highest rate of cosmetic enhancement procedures performed (42.9% annually), making them the highest likely demographic. Anti-aging and body reshaping operations are among the most common for this age range.

Geographical Analysis

North America Accounted for Approximately 43.9% of the Market Share Owing to the Strong Presence of Major Players and Increasing Technological Advancements

Manufacturers have chances to expand their operations in this region because of the rising demand for plastic surgery for advancements in North America. The area has many producers and suppliers, and its rapid economic development has increased the industrial production of plastic surgery, which has increased the demand.

There are many manufacturers and suppliers in North America, and as a result of the region's rapid economic growth, industrial production has expanded, feeding the desire for cosmetic surgery.

The market will grow as new items or technology for surgeries emerge. Rising technological developments, governmental approvals, and the introduction of new products all contribute to growth. Researchers are becoming more aware of their physical appearance, looks, body shape and many more factors related to their appearance, leading to the expansion of the market in this region. These factors show the dominance of North America.

Competitive Landscape

The major global players in the plastic surgery market include: Allergan Aesthetics (AbbVie Inc.), Cynosure LLC, Alma Lasers, Galderma, Merz Aesthetics, Lumenis Be Ltd., Candela Corporation, Bausch Health Companies Inc., Evolus, Inc. and GC Aesthetics among others.

Why Purchase the Report?

  • To visualize the global plastic surgery market segmentation based on surgical procedure type, gender, age group, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of plastic surgery market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global plastic surgery market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
Product Code: MD443

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Surgical Procedure Type
  • 3.2. Snippet by Gender
  • 3.3. Snippet by Age Group
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Rising Novel Product Launches
      • 4.1.1.2. Rising Clinical Trials and Research and Development
    • 4.1.2. Restraints
      • 4.1.2.1. High Risk and Complications Associated with these Surgeries
    • 4.1.3. Opportunity
      • 4.1.3.1. Rising Influence of Media, Social Media and the Fashion Industry
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Surgical Procedure Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 7.1.2. Market Attractiveness Index, By Surgical Procedure Type
  • 7.2. Reconstructive Surgical Procedure *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Tumor Removal Surgery
    • 7.2.4. Laceration Repair
    • 7.2.5. Maxillofacial Surgery
    • 7.2.6. Scar Revision
    • 7.2.7. Hand Surgery
    • 7.2.8. Others
  • 7.3. Cosmetic (aesthetic) Surgical Procedure
    • 7.3.1. Breast Enhancement
    • 7.3.2. Nose Reshaping
    • 7.3.3. Liposuction
    • 7.3.4. Face Lift
    • 7.3.5. Eye-lid Surgery
    • 7.3.6. Body Contouring
    • 7.3.7. Skin Rejuvenation
    • 7.3.8. Others
  • 7.4. Cosmetic Minimally-Invasive Procedures
    • 7.4.1. Botulinum Toxin Type A
    • 7.4.2. Soft Tissue Filler
    • 7.4.3. Laser Skin Resurfacing
    • 7.4.4. Chemical Peel
    • 7.4.5. Intense Pulsed Light Treatment
    • 7.4.6. Laser Skin Removal
    • 7.4.7. Others

8. By Gender

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 8.1.2. Market Attractiveness Index, By Gender
  • 8.2. Female *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Male

9. By Age Group

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.1.2. Market Attractiveness Index, By Age Group
  • 9.2. Age Group (13-19) *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Age Group (20-29)
  • 9.4. Age Group (30-39)
  • 9.5. Age Group (40-54)
  • 9.6. Age Group (55-69)
  • 9.7. Age Group (70+)

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Surgical Centers/ Clinics
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan

Australia

      • 11.5.7.4. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Allergan Aesthetics (AbbVie Inc.) *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Alma Lasers
  • 13.3. Cynosure LLC
  • 13.4. Galderma
  • 13.5. Bausch Health Companies Inc.
  • 13.6. Merz Aesthetics
  • 13.7. Candela Corporation
  • 13.8. Evolus, Inc.
  • 13.9. Lumenis Be Ltd.
  • 13.10. GC Aesthetics

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!